Adriano Dos Santos Gigante

Dr. Adriano Dos Santos Gigante

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2017 in Viruses
Verified
Journal Article
Open access
PDF file
AGAdriano Dos Santos Gigante
Adriano Dos Santos Gigante
CHCheri M. Hampton
Cheri M. Hampton
RDRebecca Dillard
Rebecca Dillard
FGFilipa Gil
Filipa Gil
MCMaria João Catalão
Maria João Catalão
MPMadalena Pimentel
Madalena Pimentel
All dsDNA phages encode two proteins involved in host lysis, an endolysin and a holin that target the peptidoglycan and cytoplasmic membrane, respectively. Bacteriophages that infect Gram-negative bacteria encode additional proteins, the spanins, involved in disruption of the outer membrane. Recently, a gene located in the lytic cassette was identified in the genomes of mycobacteriophages, which encodes a protein (LysB) with mycolyl-arabinogalactan esterase activity. Taking in consideration the complex mycobacterial cell envelope that mycobacteriophages encounter during their life cycle, it is valuable to evaluate the role of these proteins in lysis. In the present work, we constructed an Ms6 mutant defective on lysB and showed that Ms6 LysB has an important role in lysis. In the absence of LysB, lysis still occurs but the newly synthesized phage particles are deficiently released to the environment. Using cryo-electron microscopy and tomography to register the changes in the lysis phenotype, we show that at 150 min post-adsorption, mycobacteria cells are incompletely lysed and phage particles are retained inside the cell, while cells infected with Ms6wt are completely lysed. Our results confirm that Ms6 LysB is necessary for an efficient lysis of Mycobacterium smegmatis, acting, similarly to spanins, in the third step of the lysis process.

25 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
SDSicelo of Dlamini
Sicelo of Dlamini
AGAdriano Dos Santos Gigante
Adriano Dos Santos Gigante
SHSteven Hooton
Steven Hooton
RARobert Atterbury
Robert Atterbury
Salmonella causes a range of diseases in humans and livestock of considerable public health and economic importance. Widespread antimicrobial use, particularly in intensively produced livestock (e.g., poultry and pigs) may contribute to the rise of multidrug-resistant Salmonella strains. Alternative treatments such as bacteriophages have shown promise when used to reduce the intestinal carriage of Salmonella in livestock. However, the digestive enzymes and low pH encountered in the monogastric GI tract can significantly reduce phage viability and impact therapeutic outcomes. This study deployed alginate–carrageenan microcapsules with and without CaCO3 to protect a genomically diverse set of five Salmonella bacteriophages from simulated gastrointestinal conditions. None of the unprotected phage could be recovered following exposure to pH < 3 for 10 min. Alginate–carrageenan encapsulation improved phage viability at pH 2–2.5 after exposure for 10 min, but not at pH 2 after 1 h. Including 1% (w/v) CaCO3 in the formulation further reduced phage loss to <0.5 log10 PFU/mL, even after 1 h at pH 2. In all cases, phage were efficiently released from the microcapsules following a shift to a neutral pH (7.5), simulating passage to the duodenum. In summary, alginate–carrageenan-CaCO3 encapsulation is a promising approach for targeted intestinal delivery of genomically diverse Salmonella bacteriophages.

29 December 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
APAlexander Perfilyev
Alexander Perfilyev
AGAnastasiya Gæde
Anastasiya Gæde
SHSteve Hooton
Steve Hooton
SZSara Zahran
Sara Zahran
PKPANAGIOTIS KALATZIS
PANAGIOTIS KALATZIS
TSThomas Sicheritz-Ponten
Thomas Sicheritz-Ponten
Phages are typically classified as temperate, integrating into host genomes, or lytic, replicating and killing bacteria; for this reason, lytic phages are not expected in bacterial genome sequences. Here we analyse 3.6 million bacterial genome assemblies from 1,226 species and find 119,510 lytic phage genomes, which we term bacterial assembly-associated phage sequences. This represents a ~5-fold increase in the number of phages with associated hosts and raises questions about fundamental aspects of phage biology. Our analyses of bacterial assembly-associated phage sequences revealed previously undescribed phage clusters, including clusters distantly related to Salmonella Goslarviruses in Escherichia coli and Shigella , while also substantially expanding known genera such as Seoulvirus (from 16 to >300 members). Close relatives of lytic phages used therapeutically were also detected, suggesting clinical isolate sequencing unknowingly archives potential phage candidates. The discovery of complete, lytic phage genomes within bacterial assemblies challenges assumptions about the nature of the lytic lifestyle and reveals an untapped reservoir of phages.

15 July 2021 in Viruses
Verified
Journal Article
Open access
PDF file
AGAdriano Dos Santos Gigante
Adriano Dos Santos Gigante
FOFrancisco Olivença
Francisco Olivença
MCMaria João Catalão
Maria João Catalão
PLPaula Leandro
Paula Leandro
JMJosé Moniz-Pereira
José Moniz-Pereira
MPMadalena Pimentel
Madalena Pimentel
Double-stranded DNA bacteriophages end their lytic cycle by disrupting the host cell envelope, which allows the release of the virion progeny. Each phage must synthesize lysis proteins that target each cell barrier to phage release. In addition to holins, which permeabilize the cytoplasmic membrane, and endolysins, which disrupt the peptidoglycan (PG), mycobacteriophages synthesize a specific lysis protein, LysB, capable of detaching the outer membrane from the complex cell wall of mycobacteria. The family of LysB proteins is highly diverse, with many members presenting an extended N-terminus. The N-terminal region of mycobacteriophage Ms6 LysB shows structural similarity to the PG-binding domain (PGBD) of the φKZ endolysin. A fusion of this region with enhanced green fluorescent protein (Ms6LysBPGBD-EGFP) was shown to bind to Mycobacterium smegmatis, Mycobacterium vaccae, Mycobacterium bovis BGC and Mycobacterium tuberculosis H37Ra cells pretreated with SDS or Ms6 LysB. In pulldown assays, we demonstrate that Ms6 LysB and Ms6LysBPGBD-EGFP bind to purified peptidoglycan of M. smegmatis, Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis, demonstrating affinity to PG of the A1γ chemotype. An infection assay with an Ms6 mutant producing a truncated version of LysB lacking the first 90 amino acids resulted in an abrupt lysis. These results clearly demonstrate that the N-terminus of Ms6 LysB binds to the PG.

15 September 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
RARobert Atterbury
Robert Atterbury
AGAdriano Dos Santos Gigante
Adriano Dos Santos Gigante
Paul A. BarrowPaul A. Barrow
Paul A. Barrow
Resistance to antimicrobials in bacterial pathogens has become a major global public health issue that international institutions are now realizing must be tackled with a degree of urgency. A major issue is the self-transmissibility of the plasmids that carry most of the resistance genes. Scientists are now exploring ways in which the antimicrobial resistance plasmids might be tackled directly to reduce resistance. Pharmacological approaches to destabilizing plasmids have not yet been tested in vivo. Phagemids may be used to introduce genes which harm the bacteria themselves or disrupt key plasmid genes. The transfer of transmissible plasmids is mediated by thin conjugative pili which are also attachment sites for a range of lytic bacteriophages. Such phages may be used to kill bacterial cultures where fimbriae are highly de-repressed. They also select for the small number of bacterial cells which have spontaneously lost their plasmid, thereby replacing an antibiotic-resistant strain with one which is once again fully susceptible to antibiotics. This has been demonstrated both in vitro and in animal models of infection. A pharmaceutical approach is proposed to de-repress the plasmids possessed by many strains and thereby increase phage susceptibility.